Access cutting-edge endometrial cancer treatment through this clinical trial at a research site in Buffalo. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Buffalo location
Preparing your pre-screening questions…
Access endometrial cancer specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related endometrial cancer treatment provided free
Check if you qualify for this endometrial cancer clinical trial in Buffalo, NY
No-Cost Study Care
Local to Buffalo
Convenient for NY residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
HWK-007-101 is a multicenter, open-label, first-in-human (FIH) Phase 1 study evaluating HWK-007, a protein tyrosine kinase 7 (PTK7)-targeted antibody drug conjugate (ADC), in adult participants with advanced or metastatic solid tumors known to be expressing PTK7. The study employs a sequential dose escalation and dose expansion design without a control group.
Sponsor: Whitehawk Therapeutics, Inc.
Yes, this clinical trial (NCT07444814) has an active research site in Buffalo, NY that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for endometrial cancer treatment options in Buffalo, NY, this clinical trial (NCT07444814) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Buffalo research site is actively enrolling participants for this clinical trial. You'll receive care from experienced endometrial cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all endometrial cancer clinical trials near you to find additional studies recruiting in your area.
See all endometrial cancer clinical trials recruiting in Buffalo — not just this study.
Browse Endometrial Cancer Trials in Buffalo →